Schwartz LM[Author] - Search Results

Year	Number of Results
1972	1
1976	2
1980	2
1982	1
1983	2
1984	4
1985	3
1986	2
1987	1
1988	3
1989	3
1990	4
1991	2
1992	6
1993	8
1994	12
1995	16
1996	11
1997	10
1998	3
1999	13
2000	10
2001	13
2002	13
2003	3
2004	6
2005	13
2006	9
2007	13
2008	10
2009	14
2010	4
2011	10
2012	14
2013	16
2014	14
2015	11
2016	12
2017	8
2018	10
2019	10
2020	3
2021	1

1

Medical Marketing in the United States, 1997-2016.

Schwartz LM, Woloshin S. Schwartz LM, et al. JAMA. 2019 Jan 1;321(1):80-96. doi: 10.1001/jama.2018.19320. JAMA. 2019. PMID: 30620375

2

Response.

Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA. Sahasrabuddhe VV, et al. Among authors: schwartz lm. J Natl Cancer Inst. 2013 May 1;105(9):668- 71. doi: 10.1093/jnci/djt063. J Natl Cancer Inst. 2013. PMID: 23767058 Free PMC article. No abstract available.

3

Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.

Wiener RS, Schwartz LM, Woloshin S. Wiener RS, et al. Among authors: schwartz lm. Arch Intern Med. 2011 May 9;171(9):831-7. doi: 10.1001/archinternmed.2011.178. Arch Intern Med. 2011. PMID: 21555660 Free PMC article.

4

Helping Doctors and Patients Make Sense of Health Statistics.

Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S. Gigerenzer G, et al. Among authors: schwartz lm. Psychol Sci Public Interest. 2007 Nov;8(2):53-96. doi: 10.1111/j.1539-6053.2008.00033.x. Epub 2007 Nov 1. Psychol Sci Public Interest. 2007. PMID: 26161749

5

Psychotropic medications for highly vulnerable children.

McLaren JL, Barnett ER, Concepcion Zayas MT, Lichtenstein J, Acquilano SC, Schwartz LM, Woloshin S, Drake RE. McLaren JL, et al. Among authors: schwartz lm. Expert Opin Pharmacother. 2018 Apr;19(6):547-560. doi: 10.1080/14656566.2018.1445720. Epub 2018 Mar 29. Expert Opin Pharmacother. 2018. PMID: 29596008 Review.

6

Overdiagnosis: what it is and what it isn't.

Brodersen J, Schwartz LM, Heneghan C, O'Sullivan JW, Aronson JK, Woloshin S. Brodersen J, et al. Among authors: schwartz lm. BMJ Evid Based Med. 2018 Feb;23(1):1-3. doi: 10.1136/ebmed-2017-110886. BMJ Evid Based Med. 2018. PMID: 29367314 No abstract available.

7

Focusing on overdiagnosis as a driver of too much medicine.

Brodersen J, Kramer BS, Macdonald H, Schwartz LM, Woloshin S. Brodersen J, et al. Among authors: schwartz lm. BMJ. 2018 Aug 17;362:k3494. doi: 10.1136/bmj.k3494. BMJ. 2018. PMID: 30120097 No abstract available.

8

A Clear-eyed View of Restasis and Chronic Dry Eye Disease.

Schwartz LM, Woloshin S. Schwartz LM, et al. JAMA Intern Med. 2018 Feb 1;178(2):181-182. doi: 10.1001/jamainternmed.2017.7904. JAMA Intern Med. 2018. PMID: 29297040 Review. No abstract available.

9

Accountable prescribing.

Morden NE, Schwartz LM, Fisher ES, Woloshin S. Morden NE, et al. Among authors: schwartz lm. N Engl J Med. 2013 Jul 25;369(4):299-302. doi: 10.1056/NEJMp1301805. N Engl J Med. 2013. PMID: 23883375 Free PMC article. No abstract available.

10

Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing.

Kesselheim AS, Woloshin S, Lu Z, Tessema FA, Ross KM, Schwartz LM. Kesselheim AS, et al. Among authors: schwartz lm. JAMA Intern Med. 2019 May 1;179(5):707-709. doi: 10.1001/jamainternmed.2018.8121. JAMA Intern Med. 2019. PMID: 30667474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results